Meadow Creek Investment Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $446K | Buy |
1,632
+230
| +16% | +$62.9K | 0.01% | 761 |
|
|
2019
Q2 | $748K | Sell |
1,402
-480
| -26% | -$256K | 0.01% | 573 |
|
|
2019
Q1 | $948K | Sell |
1,882
-4,476
| -70% | -$2.25M | 0.02% | 479 |
|
|
2018
Q4 | $3.14M | Buy |
6,358
+1,211
| +24% | +$597K | 0.07% | 250 |
|
|
2018
Q3 | $4.71M | Buy |
5,147
+4,554
| +768% | +$4.16M | 0.09% | 206 |
|
|
2018
Q2 | $434K | Buy |
593
+404
| +214% | +$296K | 0.01% | 703 |
|
|
2018
Q1 | $302K | Sell |
189
-817
| -81% | -$1.31M | 0.01% | 843 |
|
|
2017
Q4 | $901K | Buy |
1,006
+171
| +20% | +$153K | 0.02% | 478 |
|
|
2017
Q3 | $300K | Buy |
835
+113
| +16% | +$40.6K | 0.01% | 781 |
|
|
2017
Q2 | $212K | Buy |
722
+311
| +76% | +$91.3K | 0.01% | 861 |
|
|
2017
Q1 | $145K | Buy |
411
+41
| +11% | +$14.5K | ﹤0.01% | 819 |
|
|
2016
Q4 | $68K | Buy |
+370
| New | +$68K | ﹤0.01% | 1041 |
|